WIN-Partners Co (TSE:3183) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is WIN-Partners Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. WIN-Partners Co's Free Cash Flow for the three months ended in Dec. 2023 was 円0 Mil. WIN-Partners Co's Revenue for the three months ended in Dec. 2023 was 円19,716 Mil. Therefore, WIN-Partners Co's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, WIN-Partners Co's current FCF Yield % is -1.59%.

The historical rank and industry rank for WIN-Partners Co's FCF Margin % or its related term are showing as below:

TSE:3183' s FCF Margin % Range Over the Past 10 Years
Min: -0.74 Med: 2.49 Max: 5.64
Current: -0.71

During the past 13 years, the highest FCF Margin % of WIN-Partners Co was 5.64%. The lowest was -0.74%. And the median was 2.49%.

TSE:3183's FCF Margin % is ranked worse than
69.79% of 96 companies
in the Medical Distribution industry
Industry Median: 1.135 vs TSE:3183: -0.71

WIN-Partners Co FCF Margin % Historical Data

The historical data trend for WIN-Partners Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WIN-Partners Co FCF Margin % Chart

WIN-Partners Co Annual Data

Trend

Mar12

Mar13

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

3.15

4.82

1.08

-0.21

-0.74

WIN-Partners Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of WIN-Partners Co's FCF Margin %

For the Medical Distribution subindustry, WIN-Partners Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WIN-Partners Co's FCF Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where WIN-Partners Co's FCF Margin % falls into.

WIN-Partners Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

WIN-Partners Co's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-525.166	/	70854.47
	=	-0.74 %

WIN-Partners Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	19715.525
	=	0.00 %

WIN-Partners Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of WIN-Partners Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

WIN-Partners Co (TSE:3183) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » WIN-Partners Co Ltd (TSE:3183) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031

Website

http://www.win-partners.co.jp

WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others.

WIN-Partners Co (TSE:3183) Headlines

No Headlines